Does Medicare GLP-1 Bridge (CMS) cover Zepbound?

Yes. Medicare GLP-1 Bridge (CMS) covers Zepbound for weight loss with prior authorization if your BMI is 35 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

What does Medicare GLP-1 Bridge (CMS) require to renew Zepbound?

Weight Loss — Applies to Medicare Part D plans. Subsequent fills do not require a new prior authorization unless the patient switches from one covered GLP-1 drug to a different one.

How current is this information?

The oldest review date among the policies on this page is July 8, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Medicare GLP-1 Bridge (CMS) coverage for Zepbound

Applies to Medicare Part D plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

BMI ≥ 35 (no comorbidity required)

All of:

Age ≥ 18 years
Prescription is for weight reduction and maintenance of weight reduction only (not for any other approved indication)
Patient has Medicare Part D coverage and has NOT previously received a GLP-1 through their Part D plan
Patient does NOT have type 2 diabetes, moderate-to-severe sleep apnea, or MASH
BMI ≥ 35

BMI ≥ 30 with qualifying cardiometabolic comorbidity

All of:

Age ≥ 18 years
Prescription is for weight reduction and maintenance of weight reduction only (not for any other approved indication)
Patient has Medicare Part D coverage and has NOT previously received a GLP-1 through their Part D plan
Patient does NOT have type 2 diabetes, moderate-to-severe sleep apnea, or MASH
BMI ≥ 30

Plus any one of:

Diagnosis of heart failure with preserved ejection fraction
Diagnosis of uncontrolled hypertension (systolic BP > 140 mmHg or diastolic BP > 90 mmHg despite concurrent treatment with two antihypertensive medications)
Diagnosis of chronic kidney disease stage 3a or above

BMI ≥ 27 with qualifying cardiovascular or metabolic comorbidity

All of:

Age ≥ 18 years
Prescription is for weight reduction and maintenance of weight reduction only (not for any other approved indication)
Patient has Medicare Part D coverage and has NOT previously received a GLP-1 through their Part D plan
Patient does NOT have type 2 diabetes, moderate-to-severe sleep apnea, or MASH
BMI ≥ 27

Plus any one of:

Diagnosis of pre-diabetes
Previous myocardial infarction
Previous stroke
Symptomatic peripheral artery disease

Documentation to bring

Prescriber attestation (under penalty of perjury) that information provided is true and correct
Obesity diagnosis code (E66 family) on the prescription
Documentation that patient is ≥ 18 years of age
Documentation that the GLP-1 is prescribed to reduce excess body weight and maintain weight reduction only (not for any other approved indication)
Documentation that patient has not previously received a GLP-1 through their Medicare Part D plan
Documentation that patient does NOT have type 2 diabetes, moderate-to-severe sleep apnea, or MASH
Documentation of qualifying BMI (≥ 35, or ≥ 30 with HFpEF/uncontrolled HTN/CKD stage 3a+, or ≥ 27 with pre-diabetes/prior MI/prior stroke/symptomatic PAD)
Documentation of qualifying comorbidity if BMI < 35

Quantity limits

KwikPen only — single-dose pen and vials NOT covered — 28-day or 30-day fills only

Approval and renewal

Renewal: Subsequent fills do not require a new prior authorization unless the patient switches from one covered GLP-1 drug to a different one.

Not covered when

Zepbound single-dose pen is NOT covered under Medicare GLP-1 Bridge
Zepbound vials are NOT covered under Medicare GLP-1 Bridge
Patients who have previously received a GLP-1 through their Medicare Part D plan are not eligible
Patients with type 2 diabetes must submit to their Part D plan (not eligible for Bridge)
Patients with moderate-to-severe sleep apnea must submit to their Part D plan (not eligible for Bridge)
Patients with MASH must submit to their Part D plan (not eligible for Bridge)
Patients enrolled in private fee-for-service plans, section 1876 cost contract plans, section 1833 healthcare prepayment plans, PACE organizations, fallback plans, and religious fraternal benefit plans are not eligible unless also enrolled in a standalone PDP
Prescription indicated for any approved indication other than weight reduction and maintenance of weight reduction is not eligible

Policy note: This is a short-term CMS demonstration program operating outside of Medicare Part D plan coverage, launching July 1, 2026. Only Zepbound KwikPen is covered; the single-dose pen and vials are explicitly excluded. The document notes that patients with moderate-to-severe sleep apnea must submit to their Part D plan and are NOT eligible for Bridge — therefore Zepbound's OSA indication is not covered under this program. The program uses a central processor for PA, claims processing, and pharmacy payment. PA request is pharmacy-initiated. Only 28-day or 30-day fills are covered. A new PA is required only if a patient switches from one covered GLP-1 to another.

Policy effective July 1, 2026 · verified July 8, 2026 · source: Medicare GLP-1 Bridge Prescriber Guide · View policy document (PDF)

Does Medicare GLP-1 Bridge (CMS) cover Zepbound for Weight Loss?

Policy document

Applies to Medicare Part D plans.

Qualification pathways

Documentation to bring

Quantity limits

Approval and renewal

Not covered when